Gene · 2648
Papers3,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HERC1 attenuates gemcitabine resistance of lung cancer cells by inhibiting autophagy through KAT2A ubiquitination. | Neoplasma | 2025 | 41567019 | PubTator, text mining | PubMed |
| SAGA Transcription Coactivator Complex Is Associated with Histone Locus Body HLB. | Dokl Biochem Biophys | 2025 | 41526749 | PubTator, text mining | PubMed |
| NanoBRET Tracer Development for Class I Bromodomain Target Engagement in Live Cells. | bioRxiv | 2025 | 41394747 | PubTator, text mining | PubMed |
| Erianin regulates allergic rhinitis via KAT2A-mediated histone succinylation. | J Inflamm (Lond) | 2025 | 41387864 | PubTator, text mining | PubMed |
| Exploring the Impact of Nanotherapeutics on Histone H3 and H4 Acetylation Enrichment in Cancer Epigenome: A Systematic Scoping Synthesis. | Epigenomes | 2025 | 41283357 | PubTator, text mining | PubMed |
| The canonical Wnt pathway in osteoporosis: a scoping review of key compounds and proteins modulating Wnt-induced osteogenesis. | Front Pharmacol | 2025 | 41282593 | PubTator, text mining | PubMed |
| SIRT5 affects lipid accumulation in cells of a metabolic-associated fatty liver disease model by regulating the succinylation status of HSPD1. | BMC Immunol | 2025 | 41257560 | PubTator, text mining | PubMed |
| Epigenetic regulation of TIPE3 in nasopharyngeal carcinoma and its impact on the hedgehog signaling pathway. | Cell Mol Life Sci | 2025 | 41231288 | PubTator, text mining | PubMed |
| KAT2A: a prognostic biomarker influencing proliferation and immune escape in lung adenocarcinoma. | BMC Cancer | 2025 | 41225436 | PubTator, text mining | PubMed |
| Identification of post-translational modification-related biomarkers in ischemic stroke using bioinformatics and machine learning. | Sci Rep | 2025 | 41214111 | PubTator, text mining | PubMed |
| KAT2A-driven succinylation of SRSF11 enforces spliceosome-mediated RAD52 splicing to promote homologous recombination and radioresistance in hepatocellular carcinoma. | Signal Transduct Target Ther | 2025 | 41198615 | PubTator, text mining | PubMed |
| Crocetin curbs radiation induced intestinal injury by blocking KAT2A/NLRP3 succinylation. | Sci Rep | 2025 | 41120641 | PubTator, text mining | PubMed |
| Biotechnological Insights into KAT2A-Mediated Epigenetic Regulation in Colorectal Cancer: A Transcriptomic and Functional Genomics Approach. | Iran J Biotechnol | 2025 | 41111988 | PubTator, text mining | PubMed |
| KAT2A alleviates the glucose starvation-induced mitochondrial oxidative stress and ferroptosis to promote colon cancer progression. | Apoptosis | 2025 | 41100000 | PubTator, text mining | PubMed |
| Long non-coding RNA enhances SARS-CoV-2-mediated apoptosis through epigenetic repression of angiotensin-converting enzyme 2. | J Biol Chem | 2025 | 41093073 | PubTator, text mining | PubMed |
| Cardiomyocyte lncRNA Cpat maintains cardiac homeostasis and mitochondria function by targeting citrate synthase acetylation. | Nat Commun | 2025 | 41073440 | PubTator, text mining | PubMed |
| A cancer-specific antigen drives histone acetylation by stabilizing the acetyltransferases. | Cell Rep | 2025 | 41060806 | PubTator, text mining | PubMed |
| Generative AI for navigating synthesizable chemical space. | Proc Natl Acad Sci U S A | 2025 | 41052333 | PubTator, text mining | PubMed |
| Molecular mechanism of modified KAT2A-mediated histone succinylation in asthma through inhibition of ferroptosis. | Clinics (Sao Paulo) | 2025 | 41027280 | PubTator, text mining | PubMed |
| Mammalian H4K16ac regulates the spatiotemporal order of genome replication rather than gene expression. | Nucleic Acids Res | 2025 | 40985775 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2648/papers?page=7